2012至2021年德国2型糖尿病发病率趋势:基于1100万法定参保人群健康理赔数据的分析
结果显示总体发病率持续下降,男性年龄标化发病率从2012年每10万人年1514降至2021年995,女性从1238降至796;疫情期间发病率较疫情前无显著变化。
要点
- 2012至2021年共诊断745861例新发2型糖尿病,女性占50.4%(376193例)。
- 男性年龄标化发病率由2012年每10万人年1514降至2021年995,年均下降4.6%。
- 女性年龄标化发病率由2012年每10万人年1238降至2021年796,年均下降4.8%。
核心结论
- 2012至2021年德国2型糖尿病发病率呈下降趋势,2012至2017年降幅较强,2018至2021年降幅减弱,且该趋势似乎未受新冠大流行前两年的影响。
- 尽管总体患病率上升,发病率却在下降,可能源于家庭医生的有力筛查,使诊断中位年龄提前了3至5岁。
- 作者认为仍需进一步研究以充分明确发病率下降趋势的原因,并需持续监测发病率以识别长期趋势及大流行对2型糖尿病诊断的潜在影响。
研究设计与样本
- 纳入2012至2021年研究期间按ICD-10德国修订版(ICD-10-GM)编码为E11(2型糖尿病)或E14(未特指糖尿病)的20岁及以上成人新诊断2型糖尿病病例。
- 采用欧洲标准人口计算按性别、年龄和地区分层的年度及季度年龄标化发病率(ASIR),并按10岁年龄组计算性别别粗发病率(CIR)。
- 采用校正时间趋势、季节效应和大流行效应的回归分析分析发病率趋势并评估大流行的影响。
主要发现
- 2012至2021年共诊断745861例新发2型糖尿病,其中女性50.4%(376193例);观察期内男女比例保持稳定。
- 诊断中位年龄男性从61岁降至58岁,女性从66岁降至61岁。
- 男性ASIR始终高于女性,年度差异随时间保持稳定(2012年18%;2021年20%)。
- 男性ASIR从2012年每10万人年1514降至2021年995(年均下降4.6%),女性从2012年每10万人年1238降至2021年796(年均下降4.8%);50岁以上年龄组亦观察到该下降趋势。
- 回归分析显示,与疫情前相比,大流行期间(2020和2021年)发病率无显著变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出仍需进一步研究以充分明确发病率下降趋势的原因。
- 作者指出需持续监测发病率以识别长期趋势及大流行对2型糖尿病诊断的潜在影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of the study is to describe the time trend of type 2 diabetes incidence in the largest state of Germany, Bavaria, from 2012 to 2021, and to compare the incidence rates during the pandemic period (2020-2021) to the pre-pandemic period (2012-2019). METHODS: This secondary data analysis uses health claims data provided by the Bavarian Association of Statutory Health Insurance Physicians (KVB), covering approximately 11 million insurees, accounting for 85% of the total population of Bavaria, Germany. Newly diagnosed type 2 diabetes cases in adults (≥20 years) coded as E11 (Diabetes mellitus, Type 2) or E14 (Unspecified diabetes mellitus) under ICD-10, German modification (ICD-10-GM) for the study period 2012 to 2021 were included. Annual and quarterly age-standardised incidence rates (ASIR) stratified by sex, age and region were calculated using the European standard population. Sex-specific crude incidence rates (CIR) were calculated using 10-year age groups. Regression analyses adjusted for time trends, seasonal effects, and pandemic effects were used to analyse the incidence trend and to assess the effect of the pandemic. RESULTS: Overall, 745,861 new cases of type 2 diabetes were diagnosed between 2012 and 2021: 50.4% (376,193 cases) in women. The male/female ratio remained stable over the observation period, while the median age at diagnosis decreased from 61 to 58 years in men and from 66 years to 61 years in women. ASIR were consistently higher for men compared with women, with the yearly difference remaining stable over time (2012: 18%; 2021: 20%). An overall decreasing trend in ASIR was observed during the study period, with a strong decrease from 2012 to 2017, followed by a less pronounced decline from 2018 to 2021 for both sexes. For men, ASIR decreased from 1514 per 100,000 person-years in 2012 to 995 per 100,000 person-years in 2021 (4.6% average annual reduction), and for women from 1238 per 100,000 person-years in 2012 to 796 per 100,000 person-years in 2021 (4.8% average annual reduction). This downward trend was also observed for age groups above 50 years. Regression analyses showed no significant change in incidence rates during the pandemic period (2020 and 2021) compared with the pre-pandemic period. CONCLUSIONS/INTERPRETATION: For the first time, a 10-year incidence trend of type 2 diabetes is reported for Germany, showing a strong decline from 2012 to 2017, followed by a less pronounced decline from 2018 to 2021. The incidence trend of type 2 diabetes appears not to have been affected by the first 2 years of the COVID-19 pandemic. Despite an overall increasing prevalence, the incidence is decreasing, potentially resulting from robust screening by family physicians, reducing the median age at diagnosis by 3 to 5 years. However, further investigation is needed to fully identify the reasons for the declining incidence trend. Continued incidence monitoring is necessary to identify the long-term trend and the potential effect of the pandemic on diagnoses of type 2 diabetes.
引用
- Lehner CT, Eberl M, Donnachie E, et al. Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people. Diabetologia. 2024. PMID: 38409438. doi:10.1007/s00125-024-06113-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。